C07D - Heterocyclic compounds

More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)

Patents for C07D - Heterocyclic compounds (10,420)
08/1993
08/10/1993	US5234913 Antiviral nucleoside combination
08/05/1993	WO1993015051A1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
08/05/1993	CA2107348A1 N-sulfonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
08/03/1993	CA1320959C 4h-1-benzopyran-4-one derivative or its salt, processes for producing the same and pharmaceutical composition comprising the same as active ingredient
08/03/1993	CA1320908C Diaryl compounds and their use
07/1993
07/28/1993	EP0552758A1 N-5-protected 2,5-diamino-4,6-dichloropyrimidines and process for their preparation
07/20/1993	CA1320464C Antibiotic a80190
07/13/1993	CA1320206C2 Halogen-substituted pyridines
07/13/1993	CA1320194C Substituted pyrroles
07/08/1993	WO1993013074A1 Substituted imidazole derivatives and their preparation and use
07/06/1993	US5225558 2-amino-5-cyano-1,4-dihydropyridines, and their use in medicaments
06/1993
06/30/1993	EP0548664A1 2,3,3a-5,9b-hexahydro-1H-benzo(e)indole derivatives
06/24/1993	WO1993010091A3 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
06/23/1993	EP0547165A1 Water soluble camptothecin analogues, processes and methods
06/23/1993	CN1073440A Substituted pyrazolyl pyrazole, its preparation process and intermediate, and application as herbicide
06/23/1993	CN1073430A Benzanilide derivatives
06/21/1993	CA2084442A1 Indole derivatives
06/16/1993	EP0546627A1 Mouthwash compositions
06/16/1993	CN1073169A 乙酸衍生物 Acetic acid derivatives
06/09/1993	EP0545912A2 1-Biphenylmethylimidazole derivatives, their preparation and their therapeutic use
06/09/1993	EP0545095A1 1,3-Substituted cycloalkenes and cycloalkanes as central nervous system agents
06/02/1993	EP0544488A2 Substituted phenyl phenol leukotriene antagonists
06/02/1993	EP0544166A2 Cephalosporinderivatives
06/01/1993	US5216145 Asymmetric synthesis of 3-substituted furanoside compounds
05/1993
05/27/1993	WO1993010100A1 New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/27/1993	WO1993010092A1 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
05/27/1993	WO1993010091A2 Piperidine acetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/27/1993	CA2083345A1 Cephalosporin derivatives
05/26/1993	EP0543245A1 Renin inhibiting amino acid derivatives
05/26/1993	CN1072413A 氨基酸衍生物 Amino acid derivatives
05/25/1993	CA1318321C Intermediates for the production of podophyllotoxin and related compounds and processes for the preparation and use thereof
05/25/1993	CA1318319C Removing and recovering plant polyphenols
05/20/1993	CA2081236A1 Amino acid derivatives
05/19/1993	EP0542388A1 New substituted pyrazolylpyrazoles, processes for their preparation, as well as intermediates, and their use as herbicides
05/19/1993	EP0542363A2 Piperidineacetic acid derivatives as inhibitors of fibrinogen-dependent blood platelet aggregation
05/19/1993	EP0542136A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
05/18/1993	US5212176 Adrenergic blockers
05/18/1993	CA1317945C Tricyclic pyridazopyridone derivatives
05/13/1993	WO1993009115A1 Biphenylylquinuclidines, useful as squalene synthetase inhibitors
05/13/1993	WO1993009102A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
05/12/1993	EP0540807A1 Asymmetric synthesis of 3-substituted furanoside compounds
05/12/1993	EP0540609A1 Cephalosporins and homologues, preparations and pharmaceutical compositions
05/12/1993	EP0540606A1 Cephalosporins and homologues, preparations and pharmaceutical compositions
05/12/1993	EP0540604A1 Substituted bicyclic bis-aryl compounds exhibiting selective leukotriene b 4? antagonist activity, their preparation and use in pharmaceutical compositions
05/12/1993	CN1071926A Novel pyrimido (1',6':1,2) pyrido (3,4-b) indole derivatives, pharmaceutical compositions containing them and process for preparing same
05/12/1993	CN1071919A Benzanilide derivatives
05/12/1993	CN1020612C Method for preparing antihypertensive tricyclic lactam derivs.
05/12/1993	CN1020606C Process for producing azole deriv.
05/11/1993	US5210094 Adduct formation
05/11/1993	US5210087 Cognition Activators
05/11/1993	US5210085 Method for the synthesis, compositions and use of 2'-deoxy-5-fluoro-3'-thiacytidine and related compounds
05/11/1993	US5209771 Herbicides
05/11/1993	CA1317590C 2-substituted-e-fused-¬1,2,4\|triazolo¬1,5- c\|pyrimidines, pharmaceutical compositions, and uses thereof
05/05/1993	CN1071661A Process for preparing substituted vinylbenzene
05/01/1993	CA2081674A1 Heterocyclic compounds
04/1993
04/29/1993	WO1993008206A1 Novel 2,6-disubstituted purine derivatives
04/29/1993	CA2121844A1 Novel 2,6-disubstituted purine derivatives
04/28/1993	EP0539154A1 Acridine-1,8-dione-derivatives as therapeutic agents
04/28/1993	EP0539153A1 Acridine derivative as therapeutic agent
04/28/1993	EP0538803A1 Process for the preparation of substituted vinyl benzenes
04/28/1993	EP0538303A1 Method for preparing cyclic sulphates.
04/28/1993	CN1071434A Retroviral protease inhibitors
04/24/1993	CA2080048A1 Process for the production of substituted vinylbenzenes
04/22/1993	CA2080950A1 Therapeutic agent
04/22/1993	CA2080949A1 Therapeutic agents
04/21/1993	CN1071165A Aminocoumaran derivatives, their production and use
04/20/1993	US5204466 Stereoselective preparation of biologically active isomer
04/14/1993	EP0536896A1 Imidazolidyl macrolides having immunosuppressive activity
04/13/1993	US5202447 Process of producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives
04/13/1993	CA1316175C 3-(substituted phenyl) pyrazole derivatives, salts thereof, herbicides therefrom, and process for producing said derivatives or salts
04/13/1993	CA1316171C Cephalosporin derivatives
04/07/1993	EP0535034A1 Pharmaceutically active benzoquinazoline compounds
04/07/1993	EP0513200A4 Method and compositions for the synthesis of bch-189 and related compounds
04/06/1993	CA1315794C Manufacture of haloalkyl lactams
04/05/1993	CA2079760A1 Plant growth regulator compositions
04/01/1993	WO1993006084A1 Benzanilide derivatives as 5-ht1d antagonists
03/1993
03/31/1993	EP0533878A1 Isoxazolyl imidazole derivatives, process for producing them and their use in medicaments
03/31/1993	EP0533827A1 Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same.
03/30/1993	US5198466 Oxysulfonyl urea acat inhibitors
03/30/1993	CA1315274C Process for the preparation of new oxime derivatives of 3-substituted 7-aminothiazolylacetamidocephalosporanic acid
03/24/1993	EP0533268A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993	EP0533267A1 Benzanilide derivatives as 5-HT1D antagonists
03/24/1993	EP0532515A1 Preparation of substituted piperidines.
03/23/1993	US5196438 Amino acid derivatives
03/19/1993	CA2078507A1 Benzanilide derivatives
03/19/1993	CA2078505A1 Benzanilide derivatives
03/18/1993	WO1993005059A1 Imidazolidyl macrolides
03/18/1993	WO1993004682A1 Novel 4-arylpiperazines and 4-arylpiperidines
03/18/1993	CA2095847A1 Novel 4-arylpiperazines and 4-arylpiperidines
03/17/1993	EP0532456A1 1-Acylpiperidine derivatives and their use as substance P antagonists
03/17/1993	EP0233271B1 Process for preparing cephalosporin intermediates
03/17/1993	CN1020104C Process for preparing cephene device
03/17/1993	CN1020101C Process for preparation of tricycle kentones
03/12/1993	WO1993004684A1 Novel 4-arylpiperazines and 4-arylpiperidines
03/12/1993	CA2095826A1 4-arylpiperazines and 4-arylpiperidines
03/10/1993	CN1069726A Medicaments
03/03/1993	CN1019940C Compounds of microbecide
03/02/1993	US5191093 Process for preparing crystalline calcium pseudomonate
02/1993
02/24/1993	EP0528156A1 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives
02/24/1993	EP0527801A1 Thiophene sulfonamides useful as carbonic anydrase inhibitors

1 ... 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 ... 105